Parameter | propofol | sevoflurane | p-value |
---|---|---|---|
Age (yr)* | 50(43.5–51.5) | 44(36-54.5) | 0.594 |
Body mass index (kg/m2)* | 20.8(19.4–24.2) | 21.3(19.4–26.6) | 0.642 |
ASA Physical Status (I/II) | 2/3 | 2/3 | 1.000 |
Tumor size (cm3)*# | 9.8(2.1–49.3) | 16.4(6.6–31.7) | 0.490 |
Tumor stage (I/II/III)†| 0/4/1 | 0/4/1 | 1.000 |
BCLC stage (0/A/B/C/D)§ | 0/5/0/0/0 | 0/5/0/0/0 | 1.000 |
Inflammatory grade by Scheuer scoring system (1/2) | 1/4 | 2/3 | 0.513 |
Fibrotic stage by Scheuer scoring system (1/2/3/4) | 0/0/2/3 | 1/0/2/2 | 0.419 |
HBV infection (yes/no) | 5/0 | 5/0 | 1.000 |
Anti-viral treatments to HBV (yes/no) | 3/2 | 2/3 | 0.500 |
Liver stiffness measurement by liver B-ultrasound (kPa)* | 12.8(11.0-14.2) | 11.8(7.5–16.4) | 0.756 |
Preoperative platelet count (×109/L)* | 150(124–164) | 204(118–247) | 0.253 |
Preoperative AFP level (ng/mL)* | 667(180–3147) | 32(4-415) | 0.117 |